Legal & General Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5K | Sell |
|
|||||
|
2025
Q1 | $68.2K | Sell |
|
|||||
|
2024
Q4 | $107K | Sell |
|
|||||
|
2024
Q3 | $392K | Buy |
|
|||||
|
2024
Q2 | $380K | Buy |
|
|||||
|
2024
Q1 | $355K | Buy |
|
|||||
|
2023
Q4 | $380K | Buy |
|
|||||
|
2023
Q3 | $231K | Buy |
|
|||||
|
2023
Q2 | $275K | Buy |
|
|||||
|
2023
Q1 | $141K | Buy |
|
|||||
|
2022
Q4 | $146K | Buy |
|
|||||
|
2022
Q3 | $166K | Sell |
|
|||||
|
2022
Q2 | $942K | Sell |
|
|||||
|
2022
Q1 | $1.43M | Sell |
|
|||||
|
2021
Q4 | $4.16M | Sell |
|
|||||
|
2021
Q3 | $10.4M | Buy |
|